BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Behl T, Kaur G, Fratila O, Buhas C, Judea-Pusta CT, Negrut N, Bustea C, Bungau S. Cross-talks among GBA mutations, glucocerebrosidase, and α-synuclein in GBA-associated Parkinson's disease and their targeted therapeutic approaches: a comprehensive review. Transl Neurodegener 2021;10:4. [PMID: 33446243 DOI: 10.1186/s40035-020-00226-x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 26.0] [Reference Citation Analysis]
Number Citing Articles
1 Lee N, Moon H, Park S, Moon J, Park K, Kim J, Lee J. Generation of Parkinson’s disease patient-derived human induced pluripotent stem cells line (PNUSCRi001-A) carrying a N227S mutation in GBA gene. Stem Cell Research 2022;65:102959. [DOI: 10.1016/j.scr.2022.102959] [Reference Citation Analysis]
2 Asthana J, Shravage BV. Exploring therapeutic potential of mitophagy modulators using Drosophila models of Parkinson’s disease. Front Aging Neurosci 2022;14:986849. [DOI: 10.3389/fnagi.2022.986849] [Reference Citation Analysis]
3 Naren P, Cholkar A, Kamble S, Samim KS, Srivastava S, Madan J, Mehra N, Tiwari V, Singh SB, Khatri DK. Pathological and Therapeutic Advances in Parkinson’s Disease: Mitochondria in the Interplay. JAD 2022. [DOI: 10.3233/jad-220682] [Reference Citation Analysis]
4 Morais VA, Vos M. Reduced penetrance of Parkinson’s disease models. Medizinische Genetik 2022;34:117-124. [DOI: 10.1515/medgen-2022-2138] [Reference Citation Analysis]
5 Courtin T, Brice A. Les progrès dans la génétique de la maladie de Parkinson : quelles leçons en tirer pour la pratique clinique ? Bulletin de l'Académie Nationale de Médecine 2022;206:902-908. [DOI: 10.1016/j.banm.2022.05.002] [Reference Citation Analysis]
6 Yuan Y, Ma X, Song N, Xie J. Expanding Views of Mitochondria in Parkinson's Disease: Focusing on PINK1 and GBA1 Mutations. Neurosci Bull 2022. [PMID: 35543935 DOI: 10.1007/s12264-022-00867-0] [Reference Citation Analysis]
7 Xia N, Cabin DE, Fang F, Reijo Pera RA. Parkinson’s Disease: Overview of Transcription Factor Regulation, Genetics, and Cellular and Animal Models. Front Neurosci 2022;16:894620. [DOI: 10.3389/fnins.2022.894620] [Reference Citation Analysis]
8 Ma M, Moulton MJ, Lu S, Bellen HJ. 'Fly-ing' from rare to common neurodegenerative disease mechanisms. Trends Genet 2022:S0168-9525(22)00080-4. [PMID: 35484057 DOI: 10.1016/j.tig.2022.03.018] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
9 Berdowska I, Matusiewicz M, Krzystek-korpacka M. HDL Accessory Proteins in Parkinson’s Disease—Focusing on Clusterin (Apolipoprotein J) in Regard to Its Involvement in Pathology and Diagnostics—A Review. Antioxidants 2022;11:524. [DOI: 10.3390/antiox11030524] [Reference Citation Analysis]
10 Pang SY, Lo RCN, Ho PW, Liu H, Chang EES, Leung C, Malki Y, Choi ZY, Wong WY, Kung MH, Ramsden DB, Ho S. LRRK2, GBA and their interaction in the regulation of autophagy: implications on therapeutics in Parkinson's disease. Transl Neurodegener 2022;11. [DOI: 10.1186/s40035-022-00281-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
11 Bo RX, Li YY, Zhou TT, Chen NH, Yuan YH. The neuroinflammatory role of glucocerebrosidase in Parkinson's disease. Neuropharmacology 2022;207:108964. [PMID: 35065083 DOI: 10.1016/j.neuropharm.2022.108964] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
12 Yalçin M, Malhan D, Basti A, Peralta AR, Ferreira JJ, Relógio A. A Computational Analysis in a Cohort of Parkinson's Disease Patients and Clock-Modified Colorectal Cancer Cells Reveals Common Expression Alterations in Clock-Regulated Genes. Cancers (Basel) 2021;13:5978. [PMID: 34885088 DOI: 10.3390/cancers13235978] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
13 Mandik F, Vos M. Neurodegenerative Disorders: Spotlight on Sphingolipids. Int J Mol Sci 2021;22:11998. [PMID: 34769423 DOI: 10.3390/ijms222111998] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
14 Neri M, Braccia A, Panteghini C, Garavaglia B, Gualandi F, Cavallo MA, Scerrati A, Ferlini A, Sensi M. Parkinson's disease-dementia in trans LRP10 and GBA variants: Response to deep brain stimulation. Parkinsonism Relat Disord 2021;92:72-5. [PMID: 34710740 DOI: 10.1016/j.parkreldis.2021.10.020] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
15 Sjögren M, Huttunen HJ, Svenningsson P, Widner H. Genetically Targeted Clinical Trials in Parkinson's Disease: Learning from the Successes Made in Oncology. Genes (Basel) 2021;12:1529. [PMID: 34680924 DOI: 10.3390/genes12101529] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Brunialti E, Villa A, Mekhaeil M, Mornata F, Vegeto E, Maggi A, Di Monte DA, Ciana P. Inhibition of microglial β-glucocerebrosidase hampers the microglia-mediated antioxidant and protective response in neurons. J Neuroinflammation 2021;18:220. [PMID: 34551802 DOI: 10.1186/s12974-021-02272-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
17 Parolo S, Tomasoni D, Bora P, Ramponi A, Kaddi C, Azer K, Domenici E, Neves-Zaph S, Lombardo R. Reconstruction of the Cytokine Signaling in Lysosomal Storage Diseases by Literature Mining and Network Analysis. Front Cell Dev Biol 2021;9:703489. [PMID: 34490253 DOI: 10.3389/fcell.2021.703489] [Reference Citation Analysis]
18 Behl T, Kaur I, Sehgal A, Singh S, Bhatia S, Al-Harrasi A, Zengin G, Bumbu AG, Andronie-Cioara FL, Nechifor AC, Gitea D, Bungau AF, Toma MM, Bungau SG. The Footprint of Kynurenine Pathway in Neurodegeneration: Janus-Faced Role in Parkinson's Disorder and Therapeutic Implications. Int J Mol Sci 2021;22:6737. [PMID: 34201647 DOI: 10.3390/ijms22136737] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
19 Coccia E, Ahfeldt T. Towards physiologically relevant human pluripotent stem cell (hPSC) models of Parkinson's disease. Stem Cell Res Ther 2021;12:253. [PMID: 33926571 DOI: 10.1186/s13287-021-02326-5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
20 Behl T, Kaur G, Sehgal A, Singh S, Bhatia S, Al-Harrasi A, Zengin G, Bungau SG, Munteanu MA, Brisc MC, Andronie-Cioara FL, Brisc C. Elucidating the Multi-Targeted Role of Nutraceuticals: A Complementary Therapy to Starve Neurodegenerative Diseases. Int J Mol Sci 2021;22:4045. [PMID: 33919895 DOI: 10.3390/ijms22084045] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
21 Vos M, Klein C. The Importance of Drosophila melanogaster Research to UnCover Cellular Pathways Underlying Parkinson's Disease. Cells 2021;10:579. [PMID: 33800736 DOI: 10.3390/cells10030579] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 12.0] [Reference Citation Analysis]
22 Kang JA, Jeon YJ. How Is the Fidelity of Proteins Ensured in Terms of Both Quality and Quantity at the Endoplasmic Reticulum? Mechanistic Insights into E3 Ubiquitin Ligases. Int J Mol Sci 2021;22:2078. [PMID: 33669844 DOI: 10.3390/ijms22042078] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
23 Behl T, Kaur G, Sehgal A, Bhardwaj S, Singh S, Buhas C, Judea-Pusta C, Uivarosan D, Munteanu MA, Bungau S. Multifaceted Role of Matrix Metalloproteinases in Neurodegenerative Diseases: Pathophysiological and Therapeutic Perspectives. Int J Mol Sci 2021;22:1413. [PMID: 33573368 DOI: 10.3390/ijms22031413] [Cited by in Crossref: 23] [Cited by in F6Publishing: 31] [Article Influence: 23.0] [Reference Citation Analysis]